Pulmonary Arteriopathy-Diagnostics and Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00266175|
Recruitment Status : Completed
First Posted : December 16, 2005
Last Update Posted : October 15, 2008
Postoperative stenoses of the pulmonary artery vascular system seldom occur alone; they are frequently found in connection with congenital heart defects or malformation syndromes. The resulting increase of afterload represents a serious pressure load for the right ventricle. Depending on the number and severity of the stenoses, gradual functional right ventricular failure is to be expected. Due to limited clinical experience, there has not yet been a consensus concerning the indications for the different therapeutic strategies (balloon dilatation, stent implantation, surgical dilatation techniques). Up to now, only few investigators in few centres use stents as therapy. Therefore, systematic multicenter investigations assessing larger groups of patients undergoing this procedure are not yet available. The same applies to other novel dilatation techniques, such as the use of the "cutting balloon" as therapy for rigid valve stenoses.
By comparing and analysing different invasive forms of treatment (balloon dilatation, stent implantation and surgery), we expect to achieve an optimisation of therapy.
In the study, the outcomes of different strategies as practiced now in German cardiological centers will be compared and the main factors influencing the results will be determined. On the basis of a standardized investigation before and one year after the intervention, these comparisons with respect to the reduction of stenosis and corresponding changes of right ventricular functional and anatomical changes are carried out correcting for known confounders. The assessment of the different included invasive and non-invasive diagnostical procedures with respect to their ability to detect pathological findings and their changes as result of the treatment is an important secondary target of the study.
|Condition or disease|
For patients with untreated peripheral pulmonary stenoses, the course of disease is characterised by a chronic pressure load of the right ventricle. In the medium to long term this can lead to right heart failure and cardiac arrhythmia unresponsive to therapy. The probability of these events as well as the time of their occurrence depends on the severity of the stenoses, the duration of stress and a possible additional volume load. Within the scope of the prospective study introduced here, we intend to characterise the stenoses with respect to degree and type and to document the treatment success in terms of decrease of afterload of the right ventricle. In this context, imaging and catheter-based methods as well as respective functional analyses are to be used to provide evidence of a reduction or neutralisation of the pulmonary artery stenoses.
Accordingly, the following questions, or corresponding objectives, can be identified as the base for the conduct of this clinical trial:
- Morphological and functional categorisation of the angiostenoses and standardisation of the diagnostic procedures. For this purpose, the quantitative criteria for both the morphological degree of stenosis (lumen constriction) and the functional degree of stenosis (pressure gradient) are established by means of cardiac catheterisation and angiography. Non-invasive imaging methods, which have as yet been restricted primarily to echocardiography, are complemented by the method of spin angiography. Compared to conventional angiography, this has the advantage of being less invasive and not involving radiation exposure.
- On the strength of past experience, the implantation of stents can be viewed as a very promising approach to a treatment with lasting effectiveness of pulmonary artery stenoses. The stents have the advantage of high radial forces that can be offset against the elastic recoil of the vessels occurring after sole dilatation. Furthermore, constrictions that are caused by either kinking of vessels or their compression by neighbouring structures can be dilated sufficiently by the use of stents.
- With respect to the interconnectedness of all the projects of the Competence Network for Congenital Heart Defects, one essential aspect is the standardisation of diagnostic methods of evaluating right ventricular function. The data obtained during the study are to provide the basis for the development of diagnostic guidelines.
- Concerning evaluation, particular attention is paid to the patients' self-assessment with respect to their exercise tolerance. In this context, it is a matter of interest to what degree the patients' subjective maximum stress and therefore their quality of life correlate with the objective measurement parameters. The anticipated results are of direct clinical significance for the patients, as they aim at medium to long-term relief of the right ventricle, which may effect a decrease in morbidity and therefore an improvement of the quality of life. This is of particular importance with regard to the fact that there will be a continuously increasing number of patients with congenital heart defects reaching adulthood.
|Study Type :||Observational|
|Actual Enrollment :||53 participants|
|Official Title:||Pulmonary Arteriopathy; Evaluation of Invasive Treatments of Peripheral Pulmonary Stenosis in Terms of Right Ventricular Function and Patient Exercise Tolerance|
|Study Start Date :||May 2005|
|Study Completion Date :||July 2008|
- Primary outcome measure:
- To assess the efficacy of the administered therapy, both the ectasia of the stenosed vessels in
- relation to the target diameter and the reduction of the pressure gradient in the stenosed vessel
- are indicated in percent. An evaluation of the therapeutic success takes place after twelve months.
- Definition of the primary target of therapy:
- • Expansion of the peripheral pulmonary artery stenosis to at least 80% of the vascular
- • Gradient reduction over the stenosis of at least 50%.
- • Reduction in right ventricular systolic pressure, indicated by a reduced ratio of systolic
- pressure of LV to RV. In this context, there is no definition in terms of a primary target,
- as right ventricular pressure reduction depends on a variety of parameters (such as
- number of stenoses of the entire peripheral pulmonary vasculature, potential
- additional volume load and right ventricular overall function).
- Secondary outcome measures:
- The improvement of the right ventricular systolic and diastolic function as well as reduction of
- ventricle size and of tricuspid valve incompetence are quantified by means of echocardiography,
- angiography and, where required, nuclear magnetic resonance tomography.
- An improvement in capability/quality of life is assessed by means of bicycle ergometer
- examinations as well as the SF-36 (New England Hospital Inc.) and KINDL questionnaires
- (Ravens-Sieberer & Bullinger) for adults and children respectively.
- In assessing the organ-related outcome measures, the different diagnostic imaging methods are
- compared with each other.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00266175
|Medizinische Hochschule Hannover|
|Hannover, Lower Saxony, Germany, D-30625|
|Herz-und Diabeteszentrum NRW|
|Bad Oeynhausen, North Rhine-Westphalia, Germany, D-32545|
|Sankt Augustin, North Rhine-Westphalia, Germany, D-53757|
|Universitätsklinikum des Saarlandes|
|Homburg, Saarland, Germany, D-66421|
|Deutsches Herzzentrum Berlin|
|Berlin, Germany, D-13353|
|Principal Investigator:||Martin Schneider, MD||Deutsches Kinderherzzentrum|